Key Drivers
- Cash Conversion
- Liquidity Strength
- Earnings Quality
AIAI Summary
NUTX has evolved into a real cash-generating healthcare operator with strong margins, liquidity, and earnings power, but the investment case remains highly discounted because reported growth still depends on a reimbursement mechanism, legal/governance scrutiny, and lower-confidence earnings quality that could quickly reverse the re-rating if collections or margins weaken.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Conversion
- •Liquidity Strength
- •Earnings Quality
NUTX looks fundamentally strong with high margins, robust cash flow, solid liquidity, and manageable leverage, though large minority interests, heavy receivables, and negative retained earnings temper shareholder earnings quality.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Breakout hold
- •Extended run
NUTX is in a strong last month uptrend, holding key support at $170-$171 and $149-$150, but the move is stretched so a pullback is possible if momentum fades.
Sharp rally to a fresh last month high signals strong momentum but elevated pullback risk
Sentiment & News
Key News Insights:
- •Revenue surge
- •Balance-sheet strength
- •Legal scrutiny
NUTX shows strong operational momentum with surging revenue and improved liquidity/leverage, but the stock remains clouded by an active fiduciary-duty investigation.
The news is net constructive for fundamentals, but ongoing governance concerns could cap near-term upside and keep volatility elevated
Similar Companies in Healthcare
Other companies in the same sector with AI ratings